Vimarsana
Biggest News Aggregation in the World

Ghost Cytometry News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ghost Cytometry. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ghost Cytometry Today - Breaking & Trending Today

ThinkCyte Launches New Website and Showcases VisionSortTM at Global Events - Vimarsana News

ThinkCyte Launches New Website and Showcases VisionSortTM at Global Events

TOKYO, May 7, 2024 /PRNewswire/ -- ThinkCyte today announced that it will be presenting at three major international scientific conferences in the first week

ThinkCyte advances biopharma phenotypic drug discovery programs with publication and presentation milestones - Vimarsana News

ThinkCyte advances biopharma phenotypic drug discovery programs with publication and presentation milestones

TOKYO, April 1, 2024 /PRNewswire/ -- ThinkCyte today announced the publication of a paper in the March issue of Cell Reports Methods on a new method for

ThinkCyte Reveals VisionSort™, The World's First Dual Mode, AI-Driven Cell Characterization and Sorting Platform - Vimarsana News

ThinkCyte Reveals VisionSort™, The World's First Dual Mode, AI-Driven Cell Characterization and Sorting Platform

/PRNewswire/ -- ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis, characterization, and isolation...

ThinkCyte and Axcelead DDP Collaborate to Advance Novel Phenotypic Drug Screening Methods - Vimarsana News

ThinkCyte and Axcelead DDP Collaborate to Advance Novel Phenotypic Drug Screening Methods

/PRNewswire/ -- ThinkCyte and Axcelead Drug Discovery Partners (DDP) today announced a research partnership focused on developing new approaches to screen...

PhoreMost and ThinkCyte collaborate to advance AI based drug discovery - Vimarsana News

PhoreMost and ThinkCyte collaborate to advance AI based drug discovery

PhoreMost Ltd. and ThinkCyte K.K today announced a strategic research partnership aimed at advancing modern phenotypic drug screening using artificial intelligence (AI).